The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development & Trading Update

20 Mar 2020 07:00

RNS Number : 8923G
U and I Group PLC
20 March 2020
 

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

20 March 2020

 

U and I Group PLC

 

Development & Trading Update

U+I (LSE:UAI), the specialist regeneration developer and investor, today announces an update to its anticipated development and trading gains for FY2020.

Brexit, the related slowdown in decision-making and the only recently resolved political uncertainty in the UK have continued to impact upon timing of some of our projects. In particular this has led to delays in securing planning consents following the election purdah and a further slowdown in transaction timetables. This has recently been dramatically exacerbated by the impact of Covid-19 on the decision-making process, business sentiment and economic activity. The rapidly accelerating impact of the Covid-19 crisis on transactional activity and Central and Local Government policy means that there is currently no reliable way to predict, with certainty, the timing or value of transactions. However, it is now unlikely that sufficient of the projects set out in our guidance at our interim results on 20 November 2019 will contract by 31 March 2020 to enable us to meet the lower end - £35 million - of our gains target for the year. In the normal course of events, we would expect some of the deferred projects to be realised in FY2021 and will provide further detail of these in our full year results.

Based on the projects on which we have certainty, the aggregate amount of our development and trading gains number is currently materially below that £35 million target for the full year. That said, we remain in advanced legal negotiations on several projects within our flexible and substantial development portfolio, including Harwell. If successfully concluded, these could have a material impact on our reported end of year total gains, albeit we expect that amount would still be below the £35 million lower end target. Given the confidential nature of these discussions, the Company is not yet in a position to provide a more detailed review of target gains as it believes this could prejudice its commercial position.

U+I has been actively managing its cost base and in the current climate it will be proactively reducing its operating expenses and all non-essential capital expenditure, with regular discussions to review these key areas and help mitigate risk. It also has the ability to access credit facilities should they be required to manage its liquidity needs, utilising its currently uncharged assets as security.

In addition to RNS releases once transactions close, a post close statement will be issued in early April updating the market on gains, trading and its cost mitigation actions.

Ends

 

 

 

For further information, please contact: 

 

U+I

Nicola Krafft

+44 (0) 20 7828 4777

ir@uandiplc.com

 

Camarco (Financial PR Adviser)

Geoffrey Pelham-Lane / Tom Huddart

+44 (0)20 3757 4985 / 4991

uandi@camarco.co.uk 

 

About U+I

U+I is a specialist regeneration developer and investor.

 

With a >£11.5 billion portfolio of complex, mixed-use, community-focused regeneration projects including a £147.1 million investment portfolio, we are unlocking urban sites bristling with potential in the London City Region (within one hour's commute from Central London), Manchester and Dublin. We exist to create long-term socio-economic benefit for the communities in which we work, delivering sustainable returns to our shareholders.

 

To find out more, visit www.uandiplc.com or follow us @uandiplc  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUKRRRRSUOAUR
Date   Source Headline
25th Jun 20199:27 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSAnnual Financial Report
21st Jun 201910:13 amRNSHolding(s) in Company
22nd May 20193:42 pmRNSSupplemental Dividend Record Date clarification
22nd May 20197:00 amRNSResults for the 13-months ended 31 March 2019
10th Apr 20193:16 pmRNSBlock listing Interim Review
3rd Apr 201912:19 pmRNSDirector Declaration
3rd Apr 20197:00 amRNSAppointment of Independent Non-Executive Director
28th Feb 20195:01 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSAcquisition of Pure Gym unit in Finchley
22nd Feb 20197:00 amRNSDevelopment and Trading Update
15th Feb 20197:55 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSDisposal and Acquisition
22nd Jan 20197:00 amRNSNew Trading Opportunities
21st Jan 20199:19 amRNSDirector/PDMR Shareholding
17th Jan 20194:46 pmRNSDirector/PDMR Shareholding
8th Jan 20199:18 amRNSDirector/PDMR Shareholding
20th Dec 20182:10 pmRNSDirector/PDMR Shareholding
18th Dec 20184:07 pmRNSHolding(s) in Company
18th Dec 201810:15 amRNSDirector/PDMR Shareholding
17th Dec 20188:52 amRNSDirector/PDMR Shareholding
17th Dec 20187:00 amRNSBlock listing Interim Review
15th Nov 201812:02 pmRNSDirector/PDMR Shareholding
5th Nov 201812:57 pmRNSHolding(s) in Company
30th Oct 20187:00 amRNSPlanning consent secured at Hendy Wind Farm
24th Oct 20187:00 amRNSInterim Results
15th Oct 20189:53 amRNSU+I Employee Benefit Trust - Purchase of Shares
10th Oct 20182:36 pmRNSBlock listing Interim Review
25th Sep 20187:00 amRNSPlanning approved at Kensington Church Street
31st Aug 20189:41 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
17th Jul 201812:01 pmRNSDirector/PDMR Shareholding
17th Jul 201811:59 amRNSDirector/PDMR Shareholding
17th Jul 201811:59 amRNSDirector/PDMR Shareholding
9th Jul 20182:14 pmRNSDirector/PDMR Shareholding
5th Jul 20184:16 pmRNSAGM Statement
4th Jul 20188:00 amRNSDeputy Chief Executive to take a short sabbatical
2nd Jul 20187:00 amRNSU+I selected for major Cambridge development
2nd Jul 20187:00 amRNSTotal Voting Rights
29th Jun 20184:35 pmRNSBlock listing Interim Review
27th Jun 20187:00 amRNSBlock Listing
11th Jun 20189:51 amRNSHolding(s) in Company
8th Jun 20183:57 pmRNSDirector/PDMR Shareholding
1st Jun 20187:00 amRNSEBT share transfer and purchase, and voting rights
29th May 20184:53 pmRNSHolding(s) in Company
22nd May 201811:24 amRNSDirector/PDMR Shareholding
22nd May 201811:24 amRNSDirector/PDMR Shareholding
22nd May 201811:22 amRNSDirector/PDMR Shareholding
22nd May 201810:10 amRNSAnnual Financial Report
4th May 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.